Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Differential gene expression profiling by LSD1 inhibition using novel LSD1 inhibitors (NCD25 and NCD38)


ABSTRACT: LSD1 is a demethylase of histone modification H3k4me1 and H3K4me2. We have developed novel LSD1 inhibitors (NCD25 and NCD38) and found that they are effective to myelodysplastic syndromes and leukemia cells. To understand what mechanisms are affected by these compounds, we employed gene expression profiling analyses. Gene expression profiling data were obtained from HEL, MDS-L, or CMK11-5 cells treated with DMSO (control), NCD25, or NCD38 and compared each other. Expression of eleven transcriptional factors (GFI1, CEBPA, SPI1, MNDA, TAL1, GATA1, NFE2, RXRA, HOXA9, GATA2, and PBX1) was reconfirmed by q-PCR with the same samples. Gene expression of leukemia cells was measured after 48 hours incubation with or without LSD1 inhibitors. Five independent experiments were performed using 3 cell lines (HEL, MDS-L and CMK11-5) and 2 drugs (NCD38 and NCD25).

ORGANISM(S): Homo sapiens

SUBMITTER: Masahiro Kawahara 

PROVIDER: E-GEOD-68348 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2015-04-29 | GSE68348 | GEO
2021-05-04 | GSE145397 | GEO
2021-05-04 | GSE145401 | GEO
2021-05-04 | GSE145399 | GEO
2021-07-21 | PXD017300 | Pride
2020-05-26 | PXD012954 | Pride
2020-03-31 | GSE128400 | GEO
2018-03-19 | GSE86524 | GEO
2020-11-03 | PXD020590 | Pride
2021-12-01 | GSE164559 | GEO